Rabinowitz, K.M.; Navon, M.; Edelman-Klapper, H.; Zittan, E.; Bar-Gil Shitrit, A.; Goren, I.; Avni-Biron, I.; Ollech, J.E.; Lichtenstein, L.; Banai-Eran, H.;
et al. Anti-TNFα Treatment Impairs Long-Term Immune Responses to COVID-19 mRNA Vaccine in Patients with Inflammatory Bowel Diseases. Vaccines 2022, 10, 1186.
https://doi.org/10.3390/vaccines10081186
AMA Style
Rabinowitz KM, Navon M, Edelman-Klapper H, Zittan E, Bar-Gil Shitrit A, Goren I, Avni-Biron I, Ollech JE, Lichtenstein L, Banai-Eran H,
et al. Anti-TNFα Treatment Impairs Long-Term Immune Responses to COVID-19 mRNA Vaccine in Patients with Inflammatory Bowel Diseases. Vaccines. 2022; 10(8):1186.
https://doi.org/10.3390/vaccines10081186
Chicago/Turabian Style
Rabinowitz, Keren Masha, Michal Navon, Hadar Edelman-Klapper, Eran Zittan, Ariella Bar-Gil Shitrit, Idan Goren, Irit Avni-Biron, Jacob E. Ollech, Lev Lichtenstein, Hagar Banai-Eran,
and et al. 2022. "Anti-TNFα Treatment Impairs Long-Term Immune Responses to COVID-19 mRNA Vaccine in Patients with Inflammatory Bowel Diseases" Vaccines 10, no. 8: 1186.
https://doi.org/10.3390/vaccines10081186
APA Style
Rabinowitz, K. M., Navon, M., Edelman-Klapper, H., Zittan, E., Bar-Gil Shitrit, A., Goren, I., Avni-Biron, I., Ollech, J. E., Lichtenstein, L., Banai-Eran, H., Yanai, H., Snir, Y., Pauker, M. H., Friedenberg, A., Levy-Barda, A., Segal, A., Broitman, Y., Maoz, E., Ovadia, B.,
... on behalf of the Responses to COVID-19 Vaccine Israeli IBD Group.
(2022). Anti-TNFα Treatment Impairs Long-Term Immune Responses to COVID-19 mRNA Vaccine in Patients with Inflammatory Bowel Diseases. Vaccines, 10(8), 1186.
https://doi.org/10.3390/vaccines10081186